alpha-naphthoflavone has been researched along with pyrazines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Wergifosse, B; Dubuisson, ML; Kremers, P; Marchand-Brynaert, J; Rees, JF; Trouet, A | 1 |
De Bruyne, E; Hu, J; Menu, E; Schots, R; Van Valckenborgh, E; Vanderkerken, K; Xu, D | 1 |
2 other study(ies) available for alpha-naphthoflavone and pyrazines
Article | Year |
---|---|
Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes.
Topics: Animals; Antioxidants; Benzoflavones; Cell Survival; Cells, Cultured; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Hepatocytes; Lipid Peroxidation; Male; Nitrofurantoin; Oxidation-Reduction; Oxidative Stress; Pyrazines; Rats; Rats, Wistar; tert-Butylhydroperoxide | 2001 |
Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Benzoflavones; Boronic Acids; Bortezomib; Calcium-Binding Proteins; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Drug Resistance, Neoplasm; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Multiple Myeloma; Pyrazines; Receptors, Notch; Up-Regulation | 2012 |